Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Operating Leases (2019 - 2024)

Iradimed (IRMD) has disclosed Operating Leases for 6 consecutive years, with $1424.0 as the latest value for Q4 2024.

  • On a quarterly basis, Operating Leases fell 99.91% to $1424.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $1424.0, a 99.91% decrease, with the full-year FY2024 number at $1424.0, down 99.91% from a year prior.
  • Operating Leases was $1424.0 for Q4 2024 at Iradimed, down from $2831.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $2.7 million in Q1 2020 to a low of $1424.0 in Q4 2024.
  • A 5-year average of $1.8 million and a median of $2.0 million in 2022 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: decreased 8.44% in 2020, then tumbled 99.91% in 2024.
  • Iradimed's Operating Leases stood at $2.5 million in 2020, then decreased by 10.32% to $2.2 million in 2021, then dropped by 13.32% to $1.9 million in 2022, then dropped by 15.52% to $1.6 million in 2023, then crashed by 99.91% to $1424.0 in 2024.
  • Per Business Quant, the three most recent readings for IRMD's Operating Leases are $1424.0 (Q4 2024), $2831.0 (Q3 2024), and $4231.0 (Q2 2024).